Exploring Polygenic Risk Scores and the Treatment of Complex Diseases

October 2, 2019

Hear professors from the University of Queensland share their goals of advancing polygenic risk scores in order to move them into the clinic to better treat complex diseases like immune disorders, cancer, heart disease, and psychiatric-neurological conditions. Discover how genetic variants and utilizing polygenic risk scores could unlock some of today’s most pressing questions and enable more effective treatment of genetic conditions. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel https://www.youtube.com/channel/UCxWMU29FF4kIG8YmQf6Zv0g?sub_confirmation=1 View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on